文献速递临床免疫

线性免疫印迹法在台湾系统性硬化症患者中的诊断与预后价值

The diagnostic and prognostic value of a line immunoblot assay in Taiwanese patients with systemic sclerosis.
PubMed 文献 · Clin Chim Acta · 2023-06-29

该研究回顾性纳入台中荣民总医院的全部个体,评估商业线性免疫印迹法(LIA)检测疾病特异性抗体及抗Ro52在台湾系统性硬化症(SSc)患者中的诊断性能与预后价值。LIA在2+信号强度最佳截断值下敏感性和特异性均为65.4%;结合间接免疫荧光(IIF)检测抗核抗体(ANA)结果后,最佳截断点重新定义为1+。抗Ro52阳性或SSc特异性自身抗体阴性可能提示疾病进展,联合IIF与LIA检测可能提高SSc诊断特异性。

要点

  • LIA在2+截断值下诊断SSc的敏感性和特异性均为65.4%。
  • 结合ANA-IIF结果后,LIA最佳截断点可调整为1+。
  • 抗Ro52阳性或SSc特异性抗体阴性可能与疾病进展相关。

核心结论

  • 抗Ro52阳性或SSc特异性自身抗体阴性可能提示SSc患者疾病进展。
  • 联合IIF与LIA检测可能提高SSc的诊断特异性。

研究设计与样本

  • 回顾性纳入台中荣民总医院的全部个体,评估LIA及ANA-IIF的诊断性能,并用多变量逻辑回归分析自身抗体与临床表型的关联。

主要发现

  • LIA在2+信号强度最佳截断值下敏感性为65.4%、特异性为65.4%。
  • 弥漫性皮肤型SSc(dcSSc)与自身抗体阴性、抗Scl-70阳性、抗RNA聚合酶III阳性及抗Ro52阳性相关。
  • 间质性肺病(ILD)与自身抗体阴性、抗Scl-70阳性及抗Ro52阳性相关。
  • 抗Ro52阳性还与肺动脉高压(PAH)及胃肠道受累相关。

关键数值与推荐

  • LIA最佳截断值为2+信号强度,敏感性65.4%、特异性65.4%。
  • 结合ANA结果后,LIA最佳截断点重新定义为1+。

临床怎么用

  • 在SSc诊断中可联合使用IIF检测ANA与LIA检测疾病特异性抗体,以提高诊断特异性。
  • 关注抗Ro52阳性或SSc特异性抗体阴性的患者,因其可能提示疾病进展风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: We aimed to evaluate the diagnostic performance and prognostic value of disease-specific antibodies and anti-Ro52 using a commercial line immunoblot assay (LIA) in Taiwanese patients with systemic sclerosis (SSc). MATERIALS AND METHODS: We retrospectively enrolledall individuals at the Taichung Veterans General Hospital. We evaluated the diagnostic performance of LIA, anti-nuclear antibody (ANA) by indirect immunofluorescence (IIF) and also the association between the autoantibodies and the clinical phenotype using multivariable logistic regression. RESULTS: The LIA exhibited a sensitivity of 65.4% and a specificity of 65.4%, at the optimal cutoff values of 2 + signal intensity. By taking the result of ANA into consideration, the optimal cutoff point was redefined as 1+. We observed a higher risk of diffuse cutaneous SSc (dcSSc) in those with negative autoantibodies, positive anti-Scl-70, anti-RNA polymerase III, and anti-Ro-52. Interstitial lung disease (ILD) was associated with negative autoantibodies, as well as positive anti-Scl-70 and anti-Ro52. Anti-Ro52 positivity was also associated with pulmonary arterial hypertension (PAH) and gastrointestinal tract involvement. CONCLUSION: The presence of anti-Ro52 or the absence of SSc-specific autoantibodies may potentially indicate advanced diseases in patients with SSc. The incorporation of both IIF and LIA testing may improve the diagnostic specificity of SSc.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Yen TH, Chen JP, Hsieh TY, et al. The diagnostic and prognostic value of a line immunoblot assay in Taiwanese patients with systemic sclerosis. Clin Chim Acta. 2023. PMID: 37390945. doi:10.1016/j.cca.2023.117457

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。